MIXED PHENOTYPE AML

Clinical trials for MIXED PHENOTYPE AML explained in plain language.

Never miss a new study

Get alerted when new MIXED PHENOTYPE AML trials appear

Sign up with your email to follow new studies for MIXED PHENOTYPE AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New cancer drug offered to patients through special access program

Disease control AVAILABLE

This program provides access to an experimental drug called AVM0703 for patients with various solid tumors and blood cancers. It is for people who may not have other treatment options. The drug aims to help the body's immune system fight cancer, and early reports show mostly mild…

Matched conditions: MIXED PHENOTYPE AML

Sponsor: AVM Biotechnology Inc • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

MIXED PHENOTYPE AML

Get alerted when new MIXED PHENOTYPE AML trials appear

New cancer drug offered to patients through special access program